Resident Endorsement for Smoking Reduction

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Columbia University Irving Medical Center, New York, NY
Smoking Reduction+3 More
Resident Endorsement - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a combination of a smoking cessation program and resident endorsement can improve compliance with smoke-free housing policies.

See full description

Eligible Conditions

  • Smoking Reduction
  • Smoking, Cessation
  • Smoking
  • Smoking Behaviors

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Resident Endorsement will improve 3 primary outcomes and 8 secondary outcomes in patients with Smoking Reduction. Measurement will happen over the course of Ever observing someone smoking indoors within the past 7 days measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview).

At baseline and at the 12-month follow-up
Change in salivary cotinine
Month 12
Change in number of cigarette butts
Change in number of smokers
Day 7
Number of participants with secondhand smoke observations
Month 12
Change in number of participants with secondhand smoke observations
Month 12
Change in number of cigarettes smoked per day
Change in number of participants with successful quit attempts
Change in number of quit attempts
Change in secondhand smoke exposure
Day 7
Number of hours of secondhand smoke exposure
Month 12
Change in number of hours of secondhand smoke exposure

Trial Safety

Trial Design

6 Treatment Groups

Standard NYCHA approach (control)
1 of 6
Compliance through reduction (relocation and reduction of personal smoking) and ...
1 of 6
Compliance through reduction/cessation plus resident endorsement (combined)
1 of 6
Compliance through resident endorsement
1 of 6
Compliance through relocation and cessation
1 of 6
Compliance through relocation/cessation plus resident endorsement (combined)
1 of 6
Active Control
Experimental Treatment

This trial requires 512 total participants across 6 different treatment groups

This trial involves 6 different treatments. Resident Endorsement is the primary treatment being studied. Participants will be divided into 5 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Compliance through reduction (relocation and reduction of personal smoking) and cessation
Behavioral
Smokers will be referred by the survey team to peer educators from a community-based organization trained to provide peer to peer health education including tobacco cessation support. The peer educator will coordinate smoking cessation support, including serving as a liaison between participant and research team, providing information regarding the smoke-free policy and opportunities for relocation, and connecting participant to access to tobacco replacement therapy and/or physician support if deemed appropriate.
Compliance through reduction/cessation plus resident endorsement (combined)The combined intervention will be carried out in the buildings assigned to this RCT arm, which will provide in-residence programs based on the resident endorsement treatment and the smoking relocation/cessation treatment. Both will occur simultaneously with one geared toward all building residents (resident endorsement) and the other targeting smokers (smoking relocation/cessation) with the goal of reducing both personal smoking and secondhand smoke exposure.
Compliance through resident endorsement
Behavioral
Buildings assigned will be targeted for a series of 2 in-residence programs that involve community forums and the creative arts to garner resident endorsements of smoke-free living environments. Premised on resident engagement, this arm seeks to impact social and physical dimensions of the residential environment to achieve compliance. The sessions will: 1) inform residents of risks associated with smoking and secondhand smoke; 2) identify reasons to have a smoke-free home, 3) ask residents to sign a pledge on paper and/or virtually; 4) display smoke-free signage on doors and/or social media pages with an original hashtag (#Smokefree[building address]); and 5) refer residents to the Smoke-free NYCHA website for information on the policy and existing cessation resources.
Compliance through relocation and cessation
Behavioral
Smokers will be referred by the survey team to peer educators from a community-based organization trained to provide peer to peer health education including tobacco cessation support. The peer educator will coordinate smoking cessation support, including serving as a liaison between participant and research team, providing information regarding the smoke-free policy and opportunities for relocation, and connecting participant to access to tobacco replacement therapy and/or physician support if deemed appropriate.
Compliance through relocation/cessation plus resident endorsement (combined)The combined intervention will be carried out in the buildings assigned to this RCT arm, which will provide in-residence programs based on the resident endorsement treatment and the smoking relocation/cessation treatment. Both will occur simultaneously with one geared toward all building residents (resident endorsement) and the other targeting smokers (smoking relocation/cessation) with the goal of reducing both personal smoking and secondhand smoke exposure.
Standard NYCHA approach (control)Buildings and study participants assigned to this arm will be recruited and followed over a 12-month period to assess outcomes. No additional programs or services will be delivered to the buildings or residents assigned to this arm beyond standard programs that NYCHA may provide to support the smoke-free mandate. Field staff will document any policy-related signage, activities or information to which these participants are exposed.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview) for reporting.

Who is running the study

Principal Investigator
D. H.
Prof. Diana Hernandez, PhD
Columbia University

Closest Location

Columbia University Irving Medical Center - New York, NY

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
NYCHA buildings in Manhattan & the Bronx (stratified evenly by borough) with more than 50 units, not undergoing major renovations.
Building

Patient Q&A Section

What causes smoking, cessation?

"Factors influencing [smoking cessation](https://www.withpower.com/clinical-trials/smoking-cessation) include knowledge and attitude toward smoking, perceived social support of smoking, religion, gender, and race/ethnicity. A lack of formal smoking cessation counseling may also lead to smoking." - Anonymous Online Contributor

Unverified Answer

What are the signs of smoking, cessation?

"Almost everybody who smokes has at least one sign of quitting and most have more than one sign, such as coughing up blood, and cough. Some signs of quitting are specific to smoking cessation such as coughing up blood or the feeling of tiredness." - Anonymous Online Contributor

Unverified Answer

How many people get smoking, cessation a year in the United States?

"Approximately 7.4 million US adults in the United States smoke tobacco. About 2.2 million of these are considered to be ready to quit. This leaves 1.2 million that are not smoking due to either a lack of will to quit or other reasons. The percentage that are not smoking but can consider quitting for personal health (as opposed to other reasons) is 0.4 percent. Approximately 6.5 million US adults will seek help to quit smoking in the past year and 3.8 thousand people will have stopped trying to quit smoking while 0.6 million will attempt to be wean themselves off smoking. Thus, around 26 million US adults will become smoke-free during this time." - Anonymous Online Contributor

Unverified Answer

Can smoking, cessation be cured?

"Findings from a recent study confirms that smoking, cessation can be easily achieved with some support. However, it shows that significant relapse during or near the cessation interval can occur. Smoking and cessation can be maintained without additional intervention." - Anonymous Online Contributor

Unverified Answer

What are common treatments for smoking, cessation?

"Most smokers have tried to quit smoking in the past but have had little or no success. Nicotine replacement therapy, such as nicotine patches or gum, may be useful for smoking cessation when provided in appropriate settings." - Anonymous Online Contributor

Unverified Answer

What is smoking, cessation?

"Effective support from friends, family and community members is a key factor enabling people to successfully stop smoking. This is particularly important after an attempt to quit. It seems that it is not enough to simply offer assistance to those who desire to give up smoking; those people who want help are usually best supported by friends or family to get the help they need to make it worthwhile for them to give up." - Anonymous Online Contributor

Unverified Answer

Does smoking, cessation run in families?

"Smoking among mothers and other family members is a risk factor for quitting smoking by family members, and is related to the number of years the family members smoke. Smoking cessation programs should target parental counseling and the use of positive influences to increase smoking cessation rates among family members." - Anonymous Online Contributor

Unverified Answer

What is the primary cause of smoking, cessation?

"The main reason for smoking, cessation was to quit for health or to reduce the severity of symptoms such as coughing, shortness of breath, chest pain, and loss of appetite. To find active smoking cessation clinical trials in your area, you can use Power to search by condition, treatment, or location." - Anonymous Online Contributor

Unverified Answer

How serious can smoking, cessation be?

"The current study shows that smoking is relatively easy under many circumstances. Nevertheless, our participants are willing to commit to an ambitious long-term lifestyle change. Smoking cessation may require more encouragement in certain situations than the general population. Nevertheless, smoking cessation seems to be an important lifestyle factor for the general population." - Anonymous Online Contributor

Unverified Answer

What is resident endorsement?

"Residents, in general, were hesitant to endorse some CME events, but they did like to partake in them, especially if they were free. Overall, residents felt that education and clinical experiences facilitated their learning, but resident endorsement may influence resident practice and may need to be addressed." - Anonymous Online Contributor

Unverified Answer

Does resident endorsement improve quality of life for those with smoking, cessation?

"Resident recommendation for medical care by the chief resident in each program is associated with increased quit rates, fewer visits, and improved adherence to smoking cessation therapy. Although we found limited evidence that faculty sponsorship enhances quitting rates, we found some evidence that faculty endorsement leads to improved quitting outcomes. Future research is needed to determine the full impact of resident recommendations, faculty and program sponsor support, and support from the hospital on cessation outcomes." - Anonymous Online Contributor

Unverified Answer

What is the latest research for smoking, cessation?

"The smoking cessation rate is high but the proportion of smokers reaching the target threshold of 10% is much lower than previous estimates. The percentage of smokers reached increased significantly to 21.5% from 2016 to 2017, suggesting improved treatment of smokers." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Smoking Reduction by sharing your contact details with the study coordinator.